Helix Acquisition Corp. II Class A Ordinary Shares (HLXB)

Cash burn rate (est.)	Burn method: Change in cash	Burn method: Operating income	Burn method: FCF (opex + capex)
Cash on hand (at last report)	1.79 mm	1.79 mm	1.79 mm
Cash burn (monthly)	9.62 k	48.95 k	(no burn)
Cash used (since last report)	48.89 k	248.76 k	n/a
Cash remaining	1.74 mm	1.54 mm	n/a
Runway (months of cash)	180.5	31.4	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

HLXB institutional ownership history Ownership history

95.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	33	23	+43.5%
Opened positions	13	18	-27.8%
Closed positions	3	0	NEW
Increased positions	4	0	NEW
Reduced positions	3	1	+200.0%

13F shares	Current	Prev Q	Change
Total value	156.87 bn	69.32 bn	+126.3%
Total shares	22.54 mm	14.27 mm	+57.9%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Helix Holdings II	5.02 mm	$52.05 mm	0.0%
Cormorant Asset Management	2.91 mm	$30.54 bn	NEW
BlackRock	1.50 mm	$15.74 bn	-0.1%
Adage Capital Partners GP, L.L.C.	1.40 mm	$14.70 bn	0.0%
Citadel Advisors	1.34 mm	$14.07 bn	NEW
Millennium Management	1.14 mm	$11.99 bn	NEW
Integrated Core Strategies	1.10 mm	$11.37 mm	0.0%
T. Rowe Price	1.09 mm	$11.42 mm	-3.5%
Sculptor Capital	705.00 k	$7.40 bn	NEW
Farallon Capital Management	600.00 k	$6.30 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
Cormorant Asset Management	2.91 mm	+2.91 mm	NEW
Citadel Advisors	1.34 mm	+1.34 mm	NEW
Millennium Management	1.14 mm	+1.14 mm	NEW
Sculptor Capital	705.00 k	+705.00 k	NEW
Perceptive Advisors	500.00 k	+500.00 k	NEW
Commodore Capital	500.00 k	+500.00 k	NEW
Soros Fund Management	475.11 k	+475.11 k	NEW
Laurion Capital Management	300.00 k	+300.00 k	NEW
Ghost Tree Capital	0.00	-300.00 k	EXIT
Harraden Circle Investments	257.23 k	+257.23 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

HLXB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
8 Feb 25	Chen Bihua	Class B Ordinary Shares Class A Ordinary Shares	Other	Dispose J	Yes	No	0	30,000	0.00	4,480,000
8 Feb 25	Helix Holdings II	Class B Ordinary Shares Class A Ordinary Shares	Other	Dispose J	No	No	0	30,000	0.00	4,480,000
13 Feb 24	Helix Holdings II	Class A Ordinary Shares	Grant	Acquire A	Yes	No	10	509,000	5.09 mm	509,000
13 Feb 24	Chen Bihua	Class A Ordinary Shares	Buy	Acquire P	Yes	No	10	903,600	9.04 mm	903,600
13 Feb 24	Chen Bihua	Class A Ordinary Shares	Buy	Acquire P	Yes	No	10	1,427,040	14.27 mm	1,427,040
13 Feb 24	Chen Bihua	Class A Ordinary Shares	Buy	Acquire P	Yes	No	10	69,360	693.60 k	69,360
13 Feb 24	Chen Bihua	Class A Ordinary Shares	Grant	Acquire A	Yes	No	10	509,000	5.09 mm	509,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

BridgeBio Oncology Therapeutics, Helix Acquisition Corp. II Enter Business Combination Agreement

28 Feb 25

Upon closing of the transaction, the combined company will be renamed "BridgeBio Oncology Therapeutics, Inc." The combined company's common stock is expected to be listed on Nasdaq under the ticker symbol BBOT.In

Press releases

From Benzinga Pro

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

28 Feb 25

Total proceeds, assuming no redemptions, are expected to be $450 million, combining funds held in the Helix Acquisition Corp. II trust account and a private investment in public equity (PIPE) financing Leading